These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31516612)

  • 21. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study.
    Zhou Y; Li Y; Hamblin MR; Wen X
    Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser.
    Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S
    Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Fluence Q-Switched Nd: YAG Laser Toning and Q-Switched Ruby Laser in the Treatment of Melasma:A Comparative Split-Face Ultrastructural Study.
    Omi T; Yamashita R; Kawana S; Sato S; Naito Z
    Laser Ther; 2012 Mar; 21(1):15-4. PubMed ID: 24610976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
    Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
    Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
    Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
    J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
    Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
    Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
    Laothaworn V; Juntongjin P
    J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study.
    Kong SH; Suh HS; Choi YS
    Ann Dermatol; 2018 Feb; 30(1):1-7. PubMed ID: 29386825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
    Moubasher AE; Youssef EM; Abou-Taleb DA
    Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
    Brown AS; Hussain M; Goldberg DJ
    J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
    Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
    J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of the dual-pulsed Q-switched neodymium:yttrium-aluminum-garnet laser: Comparison with conservative mode.
    Kim BW; Lee MH; Chang SE; Yun WJ; Won CH; Lee MW; Choi JH; Moon KC
    J Cosmet Laser Ther; 2013 Dec; 15(6):340-1. PubMed ID: 23789827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling.
    Vachiramon V; Sahawatwong S; Sirithanabadeekul P
    Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
    Park SJ; Park JW; Seo SJ; Park KY
    Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
    Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of the combination of Q-switched Nd:YAG laser and microneedling for melasma.
    Karadağ Köse Ö; Borlu M
    J Cosmet Dermatol; 2021 Mar; 20(3):769-775. PubMed ID: 32696614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Fractional Carbon Dioxide (CO
    Elmasry MF; Khalil MMF; Badawi A; Zaki NS; Fahim A
    Clin Cosmet Investig Dermatol; 2023; 16():705-715. PubMed ID: 36992970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypopigmentation Induced by Frequent Low-Fluence, Large-Spot-Size QS Nd:YAG Laser Treatments.
    Wong Y; Lee SS; Goh CL
    Ann Dermatol; 2015 Dec; 27(6):751-5. PubMed ID: 26719647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.